110 related articles for article (PubMed ID: 8933835)
1. Studies on tumor proliferation using monoclonal antibody, Ki 67 and expression of p53 in cancer of the uterine cervix.
Bar JK; Harlozinska A; Markowska J; Nowak M
Eur J Gynaecol Oncol; 1996; 17(5):378-80. PubMed ID: 8933835
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
3. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
Tan GC; Sharifah NA; Shiran MS; Salwati S; Hatta AZ; Paul-Ng HO
Asian Pac J Cancer Prev; 2008; 9(4):781-4. PubMed ID: 19256776
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
5. Changes of Ki-67 index in squamous cell carcinoma of the cervix during the early course of radiotherapy and prediction of prognosis.
Kamer SA; Yalman D; Ozer E; Sayhan S; Hanhan M; Ozsaran A; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):287-92. PubMed ID: 12807242
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
Padovan P; Salmaso R; Marchetti M; Padovan R
Eur J Gynaecol Oncol; 2000; 21(3):267-72. PubMed ID: 10949392
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
9. Papillary squamous cell carcinoma of the uterine cervix: an immunophenotypic appraisal of 12 cases.
Mirhashemi R; Ganjei-Azar P; Nadji M; Lambrou N; Atamdede F; Averette HE
Gynecol Oncol; 2003 Sep; 90(3):657-61. PubMed ID: 13678741
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.
Grabenbauer GG; Mühlfriedel C; Rödel F; Niedobitek G; Hornung J; Rödel C; Martus P; Iro H; Kirchner T; Steininger H; Sauer R; Weidenbecher M; Distel L
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1041-50. PubMed ID: 11072161
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer Detect Prev; 1998; 22(2):120-8. PubMed ID: 9544432
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix.
Rajkumar T; Rajan S; Baruah RK; Majhi U; Selvaluxmi G; Vasanthan A
Eur J Gynaecol Oncol; 1998; 19(6):556-60. PubMed ID: 10215440
[TBL] [Abstract][Full Text] [Related]
14. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma.
Steinbeck RG; Heselmeyer KM; Moberger HB; Auer GU
Acta Oncol; 1995; 34(2):171-6. PubMed ID: 7718254
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix.
Kanai M; Shiozawa T; Xin L; Nikaido T; Fujii S
Cancer; 1998 May; 82(9):1709-19. PubMed ID: 9576293
[TBL] [Abstract][Full Text] [Related]
16. MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy.
Oka K; Arai T
Int J Gynecol Pathol; 1996 Jan; 15(1):23-7. PubMed ID: 8852442
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous squamocellular carcinoma--immunohistochemical aspects].
Iosep I; Ivan L; Cozma L; Petrescu Z
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):509-15. PubMed ID: 21495358
[TBL] [Abstract][Full Text] [Related]
18. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
[TBL] [Abstract][Full Text] [Related]
19. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of expression of p53 protein and Ki-67 antigen in well-differentiated squamous cell carcinoma of the skin.
Shimizu T; Murakami T; Oga A; Furumoto H; Nakano J; Muto M
J Dermatol; 1999 Dec; 26(12):837-40. PubMed ID: 10659509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
